Loading...
Loading...
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of PEG ratio.
SurModics
SRDX has a PEG ratio of 1.70. SurModics's trailing-twelve-month revenue is $55.68 million.
Trinity Biotech plc
TRIB has a PEG ratio of 1.80. Trinity Biotech had $26.81 million in total cash for the latest quarter.
Meridian Bioscience
VIVO has a PEG ratio of 2.01. Meridian Bioscience's trailing-twelve-month ROE is 25.63%.
Abaxis
ABAX has a PEG ratio 4.44. Abaxis's trailing-twelve-month operating margin is 14.31%.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in